Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Cardiovascular disorder+1

Recruiting

Investigational

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ZILEBESIRAN

Contact Research Centre

Bipolar I disorder+1

Recruiting

Investigational

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational

Poland

Participants:18–64 years
Substances:Trospium Chloride

Contact Research Centre

Bipolar I disorder+1

Recruiting

InvestigationalNo placebo

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Bipolar I disorder+1

Recruiting

Investigational

Study of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder

Investigational

Poland

Participants:18–64 years
Substances:Trospium Chloride

Contact Research Centre

Alcoholism

Recruiting

Registered drug

Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Sodium Oxybate

Contact Research Centre

Dyslipidaemia

Recruiting

Investigational

Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rbd5044 Sodium

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Choroidal neovascularisation

Not recruiting

Registered drugNo placebo

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Faricimab

Contact Research Centre

Primary progressive multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Poland

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

Poland

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Breast cancer metastatic+2

Not recruiting

Registered drugNo placebo

Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Malignant melanoma

Not recruiting

Registered drug

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Find therapies in clinical trials near you

13 trials match your criteria

Cardiovascular disorder+1

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Bipolar I disorder+1

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Bipolar I disorder+1

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder

Bipolar I disorder+1

Study of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder

Alcoholism

Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

Dyslipidaemia

Study of RBD5044 in Adults with Mixed Dyslipidemia to Evaluate its Safety and Effectiveness

Arteriosclerosis

Study of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Choroidal neovascularisation

Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Primary progressive multiple sclerosis

Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Multiple sclerosis+1

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Breast cancer metastatic+2

Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment

Malignant melanoma

Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.